A & M IMAGING SERVICES LIMITED
Company number SC308719 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: A & M Imaging Services Limited
1. Financial Health Score: A-
Explanation: The patient is in excellent financial condition and has shown a remarkable recovery in recent years. After a period of stagnant growth and dangerously thin liquidity, the business has rapidly built up its cash reserves and working capital. The only reason this isn't a straight 'A' is the introduction of new long-term debt, which requires monitoring, and the natural limitations of assessing a micro-entity where detailed profit and loss data is kept private. Overall, the company’s financial immune system is robust, and it is well-positioned to weather future economic illnesses.
2. Key Vital Signs
- Blood Pressure (Liquidity): Historically low, now perfectly healthy. In 2024, the company’s working capital (Net Current Assets) was a dangerously thin £6,293, meaning it had almost no buffer to pay short-term debts. By 2025, this ballooned to a very healthy £68,236. The current ratio (current assets divided by current liabilities) jumped from 1.07 to 2.27. The business is no longer living paycheck to paycheck; it has a strong pulse and excellent short-term liquidity.
- Bone Density (Equity Foundation): Strong and steadily calcifying. Net Assets have grown consistently from £72,785 in 2016 to £171,131 in 2025. This represents a sustained accumulation of retained profits, meaning the business is building a solid structural foundation rather than paying out all its gains.
- Cholesterol Levels (Debt Management): Rebalanced. Short-term creditors dropped significantly from £81,630 to £53,707, which is a major factor in the improved liquidity. However, a new long-term debt of £28,768 has appeared on the balance sheet. This is akin to shifting weight from harmful "bad cholesterol" (short-term pressure) to "manageable cholesterol" (structured long-term debt), which is a healthy financial maneuver.
- Muscle Mass (Asset Base): Growing. Total assets grew from £205,196 to £253,606, and fixed assets grew from £117,273 to £131,663. The business is actively investing in its operational "muscle" (likely printing equipment, given the industry classification), which is vital for future revenue generation.
3. Diagnosis
The financial data reveals a business that has undergone a highly successful financial rehabilitation over the last 12 months.
For several years (2019-2023), the company exhibited symptoms of "working capital anemia"—total assets were growing, but they were financed by increasingly heavy short-term creditor pressure. By 2024, the business had £81,630 in current liabilities but only £87,923 in current assets, leaving it highly vulnerable to cash flow shocks.
In the 2025 fiscal year, the patient received a clean bill of health through what appears to be a combination of strong cash generation and strategic debt restructuring. The significant reduction in short-term creditors, coupled with the introduction of long-term debt, suggests the company may have refinanced short-term obligations (like HP/leasing agreements on printing equipment) into longer-term structures, instantly relieving short-term blood pressure. Furthermore, the simultaneous growth in current assets and fixed assets indicates the business is generating strong cash flow from operations—enough to comfortably service its debts, invest in new equipment, and build a substantial cash buffer.
4. Recommendations
While the patient is currently in peak condition, preventative care and strategic planning are required to maintain this health:
- Cardiovascular Exercise (Put Cash to Work): With £68,236 in net current assets, the company has a healthy surplus of cash or near-cash equivalents. While this provides safety, excess cash sitting idle can suffer from inflationary atrophy. Consider whether this liquidity can be invested into higher-yield instruments, used to pay down the new long-term debt early, or deployed into revenue-generating marketing and equipment.
- Monitor the New Long-Term Debt: The £28,768 in long-term creditors is a new symptom. Ensure the repayment terms are favorable and that the cash flow generated by the newly acquired fixed assets comfortably covers these instalments. Regularly check the interest rate "vital signs" on this debt.
- Key-Person Insurance: As a micro-entity with only 5 employees and a single Person with Significant Control (Mr. Mark Morris), the business has a high "concentration risk." If the key director were to fall ill, the company's ability to operate could be severely compromised. Ensure adequate key-person insurance and succession planning are in place to protect this healthy financial organism.